Your trusted source for investing success

Tag: jansen

Achillion Announces Results of Janssen’s Phase 2a Trial

Achillion Pharmaceuticals announced today that new interim results from a phase 2a study being conducted by Alios BioPharma, part of the Janssen Pharmaceutical Companies (Janssen), were published as part of the abstracts released for the upcoming European Association for the Study of the Liver (EASL) Special Conference.

Passport Potash Issues Statement on Uralkali Announcement

Passport Potash, Inc. (TSXV:PPI,OTCQX:PPRTF) issues a statement about recent developments in the potash industry, specifically on Russian potash producer OAO Uralkali announcing its exit from the sales organization Belarusian Potash Co., which has had an inordinate negative effect on potash stocks. Passport Potash agrees with a statement made by K+S

Enter Your Log In Credentials

Privacy & Legal Policy

Privacy Policy

Investing News Network